Post Covid 19 Syndrome clinical trials

Explore recruiting post covid 19 syndrome clinical trials.

Recruiting post covid 19 syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Post Covid 19 Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 2a, double-blind, randomized, placebo-controlled trial of methylprednisolone versus placebo in patients with cognitive deficits in post-COVID-19 syndrome (PCS) - PoCoVIT

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase II proof-of-concept, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of plitidepsin in adults with post-COVID-19 Condition (PCC)

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A parallel-group treatment, phase 2a, double-blind, placebo-controlled 2-arm study to show improvement of physical function in SF-36 (SF-36-PF) in participants treated with Vericiguat compared to placebo tablets participants with post-COVID-19 syndrome without (PCS) or with (PCS/CFS) fulfillment of ME/CFS criteria - VERI-LONG

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized adaptive assessment of post COVID syndrome treatments (RAPID): Evaluating the Efficacy of Bupropion for the Treatment of Post-COVID-19 Syndrome-associated Fatigue (ELAPSE)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A RANDOMIZED, PLACEBO-CONTROLLED, TRIPLE-BLIND CLINICAL TRIAL TO INVESTIGATE TREATMENT EFFECTS AND SAFETY OF GINKGO BILOBA EXTRACT EGB 761® IN PARTICIPANTS WITH COGNITIVE IMPAIRMENT ASSOCIATED WITH POST-COVID-19 SYNDROME

Spain, Germany, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

sElective Serotonin reuPtake inhibitoRs In posT-covid: ESPRIT

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

Post Covid 19 Syndrome trials by city

Post Covid 19 Syndrome in Toronto Post Covid 19 Syndrome in Vancouver Post Covid 19 Syndrome in Montreal Post Covid 19 Syndrome in Calgary Post Covid 19 Syndrome in Edmonton Post Covid 19 Syndrome in Ottawa Post Covid 19 Syndrome in Winnipeg Post Covid 19 Syndrome in Quebec City Post Covid 19 Syndrome in Hamilton Post Covid 19 Syndrome in Kitchener Post Covid 19 Syndrome in London Post Covid 19 Syndrome in Halifax Post Covid 19 Syndrome in New York Post Covid 19 Syndrome in Los Angeles Post Covid 19 Syndrome in Chicago Post Covid 19 Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease